
Mayumi Fujita MD
Professor, Dermatology, University of California San Diego
Join to View Full Profile
200 W Arbor DrSan Diego, CA 92103
Phone+1 800-926-8273
Fax+1 888-539-8781
Dr. Fujita is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonResidency, Dermatology, 1999 - 2002
University of WashingtonInternship, Internal Medicine, 1998 - 1999
Faculty of Medicine Kyoto UniversityClass of 1983
Certifications & Licensure
CA State Medical License 2025 - 2027
CO State Medical License 2002 - 2027
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Human Alpha-1 Antitrypsin Suppresses Melanoma Growth by Promoting Tumor Differentiation and CD8T-Cell-Mediated Immunity.Takeshi Yamauchi, Yuchun Luo, Dinoop Ravindran Menon, Kasey Couts, Sana Khan
Biomolecules. 2026-01-12 - 2 citationsDownregulatedContributes to Tumor Progression and Targeted Therapy Resistance in Human Metastatic Melanoma Cells.Zili Zhai, Takeshi Yamauchi, Karenna Sandoval, Kira Villarreal, Man Wai Charlotte Kwong
Cells. 2025-06-17 - 12 citationsEGCG suppresses PD-1 expression of T cells via inhibiting NF-κB phosphorylation and nuclear translocation.Zhong-Da Li, Fangfang Liu, Yanqiao Zeng, Yingnan Liu, Wenhe Luo
International Immunopharmacology. 2024-05-30
Press Mentions
Olatec Therapeutics Announces Results Showing Dapansutrile Reduces Tumor Growth in a Mouse Model of MelanomaApril 28th, 2021
Session InformationMarch 6th, 2016
From HIV to Cancer, IL-37 Regulates Immune SystemNovember 3rd, 2014
Grant Support
- Role of NLRs in MelanomaVA EASTERN COLORADO HEALTH CARE SYSTEM2025–2029
- The role of IL-37 in human regulatory T cellsUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
- The role of IL-37 in human regulatory T cellsUNIVERSITY OF CALIFORNIA, SAN DIEGO2021–2026
- Autoinflammation in Human MelanomaVA EASTERN COLORADO HEALTH CARE SYSTEM2012–2025
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









